Sonoma Pharmaceuticals (SNOA) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts SNOA Hot Sheet
Join SI Premium – FREE
Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q3 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $4 million.
For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Palantir and Nebius partner on sovereign AI infrastructure
- India asked Google to block search results linking to gender-test kit Peekaboo - Reuters
- Ladenburg Thalmann Starts Hawaiian Electric (HE) at Sell
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
